Akari Therapeutics Plc

Active New York, NY

Akari Therapeutics Plc Overview

Akari Therapeutics Plc filed as a Foreign Business Corporation in the State of New York on Wednesday, February 22, 2012 and is approximately twelve years old, as recorded in documents filed with New York Department of State. A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state they originally filed in. This does not necessarily mean that they are from outside the United States.

Name
David Horn Solomon ~ Background Report ~	Chief Executive Officer
Roshwalb Gur ~ Background Report ~	CEO
Roshwalb Gur ~ Background Report ~	Chief Executive Officer

New York Department of State

Filing Type:	Foreign Business Corporation
Status:	Active
State:	New York
County:	New York
State ID:	4205807
Date Filed:	Wednesday, February 22, 2012
DOS Process	Akari Therapeutics, Plc
Source Record	NY DOS

Corporate Notes

Date	Type	Note
2/22/2012	Name History/Actual	Morria Biopharmaceuticals Plc
9/19/2013	Name History/Actual	Celsus Therapeutics Plc
12/3/2015	Name History/Actual	Akari Therapeutics, Plc

Source

New York Department of State
Data last refreshed on Sunday, April 28, 2024

What next?

Follow

Receive an email notification when changes occur for Akari Therapeutics Plc.

Notifications include:

New company roles
Change in active status
Location updates
New connections

Create Account

Create a free account to access additional details for Akari Therapeutics Plc and other profiles that you visit

Benefits include:

Access to more records
Full screen network visualizer
Follow profiles
See how people are connected

Create Account

Akari Therapeutics Plc

Active New York, NY